Addex Therapeutics Ltd - Company Profile
Powered by 
All the data and insights you need on Addex Therapeutics Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Addex Therapeutics Ltd Strategy Report
- Understand Addex Therapeutics Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Addex Therapeutics Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| IL293356A | Application | Mono-phosphate salt of 6-fluoro-2-[4-(pyridin-2-yl)but-3-yn-1-yl]imidazo[1,2a]pyridine and polymorphs thereof as negative allosteric modulator of mglu5 receptor | A61K31/437; A61K31/444; A61P1/04; A61P1/14; A61P25/00; A61P25/04; A61P25/14; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P25/32; A61P25/36; A61P29/00; A61P3/04; C07B2200/13; C07D471/04 | July 01, 2022 |
| KR1020220088960A | Application | mGlu5 6--2-[4--2--3--1-][12-a] - MONO-PHOSPHATE SALT OF 6-FLUORO-2-[4-PYRIDIN-2-YLBUT-3-YN-1-YL]IMIDAZO[12A]PYRIDINE AND POLYMORPHS THEREOF AS NEGATIVE ALLOSTERIC MODULATOR OF MGLU5 RECEPTOR | A61K31/437; A61K31/444; A61P1/04; A61P1/14; A61P25/00; A61P25/04; A61P25/14; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P25/32; A61P25/36; A61P29/00; A61P3/04; C07B2200/13; C07D471/04 | June 28, 2022 |
| CA2925040C | Grant | MONO-PHOSPHATE SALT OF 6-FLUORO-2-[4-(PYRIDIN-2-YL)BUT-3-YN-1 -YL]IMIDAZO[1 ,2A]PYRIDINE AND POLYMORPHS THEREOF AS NEGATIVE ALLOSTERIC MODULATOR OF MGLU5 RECEPTOR | A61K31/437; A61K31/444; A61P1/04; A61P1/14; A61P25/00; A61P25/04; A61P25/14; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P25/32; A61P25/36; A61P29/00; A61P3/04; C07B2200/13; C07D471/04 | March 22, 2022 |
| US11071729B2 | Grant | 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2'-ones | A61K31/444; A61K31/4545; A61K31/5377; A61K45/06; A61K47/10; A61K47/44; A61K9/0014; A61K9/0019; A61K9/08; A61K9/10; A61K9/2009; A61K9/2013; A61K9/2018; A61K9/2059; A61P25/00; A61P25/06; A61P25/08; A61P25/10; A61P25/12; A61P25/14; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P25/32; A61P25/34; A61P25/36; A61P3/04; A61P9/10; C07D211/86; C07D401/04; C07D491/107; C07D493/10 | July 27, 2021 |
| GB202106872D0 | Application | Novel compounds | June 30, 2021 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer